Skip to main content

Table 3 Clinical characteristics of the subjects

From: Circ_0070934 promotes MGAT3 expression and inhibits epithelial-mesenchymal transition in bronchial epithelial cells by sponging miR-199a-5p

Groups

Control (N = 43)

Asthma (N = 38)

P

Sex (male/female)

27/16

22/16

0.653

Age (y)

40.30 ± 10.40

40.73 ± 13.65

0.738

BMI (kg/m2)

26.43 ± 3.51

25.30 ± 3.46

0.606

FEV1% pre

108 ± 8.67

88.19 ± 27.27

0.024

FEV1/FVC (%)

83.00

73.55

0.016

(97.70–114.10)

(67.13–82.00)

 

EOS (× 109/L)

0.12 (0.07–0.21)

0.36 (0.20–0.71)

 < 0.001

EOS%

1.80 ± 1.33

6.00 ± 4.38

 < 0.001

FeNO (ppb)

19.00

61.00

 < 0.001

(14.00–27.00)

(26.50–93.50)

 
  1. BMI body mass index, FEV1% pre percent of predicted forced expiratory volume in 1 s, FVC forced vital capacity, EOS eosinophils, FeNO fraction of exhaled nitric oxide
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us